Galapagos | GLPG - Le Chiffre D'Affaires De Vente

Prix De L'Action
28.82
Variation Quotidienne
0.20 0.70%
Mensuellement
2.27%
Annuel
17.06%
Q1 Prévisions
27.72




Ventes Changement Date
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Biogen USD 2.28B 250M 2025-12
Genmab DKK 5.86B 580M 2025-06
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Incyte USD 1.51B 140M 2025-12
Merck EUR 5.32B 890M 2025-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.91B 144M 2025-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
UCB EUR 3.49B 129M 2025-06
Vertex Pharmaceuticals USD 3.19B 110M 2025-12